Comparison of the Use of Immune Checkpoint Inhibitor/Tyrosine Kinase Inhibitor and Tyrosine Kinase Inhibitor Alone for Patients With Low Risk Metastatic Renal Cell Carcinoma
In Vivo · 2025
DOI: 10.21873/invivo.14142 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift In Vivo, 2025. Verfasst von Masaharu Oki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Renal Transplantation, Nagasaki University Hospital, Nagasaki, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Protein Kinase Inhibitors, Immune Checkpoint Inhibitors, Kidney Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology and Renal Transplantation, Nagasaki University Hospital, Nagasaki, Japan.
- Department of Urology and Renal Transplantation, Nagasaki University Hospital, Nagasaki, Japan ohba-k@nagasaki-u.ac.jp.
Zitieren
APA
Oki, M., Ohba, K., Mukae, Y., Matsuda, T., Nakanishi, H., Mitsunari, K., Matsuo, T., Mochizuki, Y., & Imamura, R. (2025). Comparison of the Use of Immune Checkpoint Inhibitor/Tyrosine Kinase Inhibitor and Tyrosine Kinase Inhibitor Alone for Patients With Low Risk Metastatic Renal Cell Carcinoma. In Vivo. https://doi.org/10.21873/invivo.14142
Vancouver
Oki M, Ohba K, Mukae Y, Matsuda T, Nakanishi H, Mitsunari K, et al. Comparison of the Use of Immune Checkpoint Inhibitor/Tyrosine Kinase Inhibitor and Tyrosine Kinase Inhibitor Alone for Patients With Low Risk Metastatic Renal Cell Carcinoma. In Vivo. 2025. doi:10.21873/invivo.14142
BibTeX
@article{Oki2025,
author = {Oki, Masaharu and Ohba, Kojiro and Mukae, Yuta and Matsuda, Tsuyoshi and Nakanishi, Hiromi and Mitsunari, Kensuke and Matsuo, Tomohiro and Mochizuki, Yasushi and Imamura, Ryoichi},
title = {Comparison of the Use of Immune Checkpoint Inhibitor/Tyrosine Kinase Inhibitor and Tyrosine Kinase Inhibitor Alone for Patients With Low Risk Metastatic Renal Cell Carcinoma},
journal = {In Vivo},
year = {2025},
doi = {10.21873/invivo.14142}
}
EUVIMED